Currently predicting for Thu, 4 Jun 2026

ALKS Prediction Chart

ALKS Predictions History

Latest community submissions for ALKS.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 6, 2025 $30.67 -1.27% $30.99 V 98.96% 2
Oct 6, 2025 $30.81 -0.79% $30.99 V 99.43% 4
Oct 6, 2025 Bullish $30.99 X 0
Jun 12, 2024 $24.53 -1.06% $24.84 X 98.74% 1
Jun 12, 2024 $24.63 -0.66% $24.84 X 99.14% 2
Jun 12, 2024 $29.00 +19.88% $24.84 V 83.25% 1
JS JS Pro
Jun 6, 2022 $29.09 -0.75% $28.34 V 97.35% 1
Jun 6, 2022 Bullish $28.34 X 1
May 6, 2019 $28.13 -1.47% $28.55 X 98.53% 1
joe1234 joe1234 Pro
May 6, 2019 $29.11 +1.96% $28.55 X 98.04% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ALKS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ALKERMES PLC
Alkermes
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and prevention of opioid dependence; RISPERDAL CONSTA for the tre...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE